Ind-Swift Laboratories Limited Share Price & Technical Analysis
INDSWFTLAB · ₹156.7 (-0.27%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹156.7
-0.27%
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyp…
Price chart
Seasonality
Jun has 5 positive and 0 negative years (last 5 years shown)
2% return in Jun, 26% avg return in past 3 year Jun month.
65% return in 2026, 9% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 27% | 29% | -5% | 2% | 11% | 2% | – | – | – | – | – | – | 65% |
| 25 | 2% | -23% | -2% | -15% | 12% | 38% | -7% | -9% | -2% | 6% | -5% | -9% | -16% |
| 24 | 6% | -2% | -8% | 18% | -13% | 20% | 27% | -12% | -14% | -10% | -21% | 14% | 4% |
| 23 | -8% | -5% | -11% | 25% | -1% | 20% | 10% | 7% | -15% | -5% | 6% | 13% | 38% |
| 22 | 12% | -11% | -2% | -1% | -14% | 3% | 0% | 0% | -8% | -2% | 19% | 7% | 2% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is based in Manimajra, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹14.10B
P/E ratio
33.49
52W high
₹173.3
52W low
₹87.15
Volume
10,21,099
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,732
Frequently asked questions
- What is Ind-Swift Laboratories Limited share price today?
- Ind-Swift Laboratories Limited (INDSWFTLAB) last traded around ₹156.7 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does INDSWFTLAB have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for INDSWFTLAB. Download the app for real-time alerts.
- How can I analyze Ind-Swift Laboratories Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.